Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019158 (
hepatitis
)
30,205
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The human-blood
plasma glutamate carboxypeptidase
(
PGCP
) is a proteinase that acts on the unsubstituted N- and C-termini of dipeptides. It has been suggested that this
PGCP
is involved in the release of thyroxine. Furthermore, research has suggested that its activity is up-regulated in
hepatitis
-C-virus-infected patients with hepatocellular carcinoma. In this study expressed human
PGCP
in the baculovirus expression system was produced by a Sf9 insect cell line with aim to prepare sufficient amounts of active recombinant enzyme for a subsequent biological characterization. Recombinant
PGCP
was expressed and secreted into the medium in the form of an inactive proenzyme. It was gradually converted into an active form in the medium after three days, with the highest expression of the active form on day six. The protein was sequentially purified by a combination of various liquid chromatographies, such as hydroxyapatite, ion exchange, and gel chromatography, and as final step with affinity chromatography on Phe-Leu-Sepharose. The human
PGCP
was purified as an active enzyme in the dimer form and as inactive precursor protein. The dipeptidase activity was confirmed by measuring the hydrolysis of the Ser-Met dipeptide at a slightly acidic pH.
...
PMID:Baculoviral expression and characterization of human recombinant PGCP in the form of an active mature dimer and an inactive precursor protein. 2095 Dec 14